The suitability was investigated of the segmental perfusion technique under an occluding balloon (which prevents the contamination of the test segment by upper digestive secretions and pancreatic proteolytic enzymes) for measuring immunoglobulin A (IgA) and serum albumin outputs into the jejunal lumen. The influence of the perfusion rate and of the transintestinal water movements in the 40 cm long test segment was studied in 11 healthy subjects. IgA and serum albumin outputs did not differ significantly when the same isotonic solution was perfused at rates of 5 or 10 ml/min, nor when water absorption was stimulated by the presence of glucose. A possible artefact linked to intestinal wall distension by the occluding balloon was evaluated in eight subjects with complete exocrine pancreas insufficiency. IgA and serum albumin outputs obtained under the occluding balloon were compared with those found with the triple lumen non-occlusive method. Care was taken to achieve a similar flow rate and solute composition of the fluid entering the test segment with both techniques in each subject. Under these conditions, IgA and serum albumin outputs measured with both methods did not differ significantly. These findings validate the use of the segmental perfusion technique under an occluding balloon to measure IgA and serum albumin outputs into the human small intestine.
It is well established that immunoglobulin A (IgA), mainly in its locally produced 11S secretory 'form' (S-IgA) , is the main type of immunoglobulin in small intestinal secretion.1 However, its secretion rate in vivo cannot be deduced from its concentration in the intraluminal fluid. Indeed, this concentration not only reflects the local production of IgA, but also depends on at least three factors: (1) mixing of local secretion with gastric, pancreatic, biliary and overlying bowel secretions; (2) transintestinal water movements: and (3) intraluminal proteolysis, even if the secretory piece makes S-IgA more resistant to pancreatic enzymes.2 Moreover, this last factor increases the difficulties of IgA assay. Effect of proximal occluisioni of intestinal liumen on serum albumin and IgA olutputs This study was performed in eight patients with complete exocrine pancreatic insufficiency (five subjects with chronic alcoholic pancreatitis and three subjects with carcinoma of the head of the pancreas). Two subjects had a complete obstruction of the main bile duct. The perfusion tube was slightly modified as shown in Fig. 1 , so that the tube could be used in the same patient, either as above for healthy subjects, the balloon being inflated, or as a triple-lumen tube.6
Each subject underwent two consecutive perfusion studies. After an overnight fast, serum albumin and IgA jejunal outputs were measured by the triple lumen technique. The test solution 1 was infused at the duodenojejunal junction through lumen A at a rate of 10 ml/min; after a 60 minute equilibration period, four 20 minute proximal (lumen C) and distal (lumen D) samples were collected. Proximal sampling was carried out by gentle aspiration with a syringe at the constant rate of 2 ml/min and distal collection was made by free siphonage. The flow rate and composition of the fluid entering the test segment were immediately determined by measuring the concentration of PEG in the test solution and the osmolality and the concentrations of PEG and electrolytes in the proximal samples. Thereafter, during the afternoon, serum albumin and IgA outputs were determined at the same jejunal site, using the proximal occlusive balloon technique. In each subject, the electrolyte and mannitol composition and the rate of infusion in lumen C of the test solution mimicked as closely as possible those of the fluid entering the test segment during the preceding triple lumen tube perfusion. Four 20 minute samples were taken through lumen D by siphonage after a 60 minute equilibration period. Thus, in each subject, the site and length of the test segment CD, the osmolality, electrolyte composition, and flow rate of the perfused solution were the same during the two perfusions, although the intestinal lumen was occluded in the first, but not in the second. Patients continued to fast during the whole study, and received an intravenous infusion of glucose and balanced electrolyte solution (with insulin when necessary).
All perfusate samples obtained in normal subjects and patients were recovered at 0°C. Diisopropylfluorophosphate (DFP), a potent proteolysis inhibitor, was added to an aliquot fraction which was homogenised and stored at -20°C until serum albumin and IgA were measured. (Fig. 4) were 66±+10 (n=7) and 70±14 (n= 7) jig respectively during triple lumen tube experiments and 90 ±18 (n=7) and 67 + 18 (n=7) pg respectively during perfusions under the occlusive balloon, the differences observed for these two substances between the two perfusion techniques not being statistically significant. There were also no significant differences between patients with or without obstruction of the main bile duct.
Discussion
Occlusion of the intestinal lumen above the test segment in order to prevent the contamination of the perfusate by pancreatic enzymes is necessary and sufficient10 to avoid significant intraluminal proteolysis. However, the presence of this occlusive balloon could affect the local or regional blood and lymphatic circulation, and influence the intraluminal secretion of circulating polypeptides, such as serum albumin and 7S IgA. This possible artefact, as well as that associated with the absence of bile salts in the perfusate, does not seem important, as shown the similarity between serum albumin and IgA outputs measured by the occlusive balloon method and by the triple lumen tube technique in patients with complete exocrine pancreas insufficiency who do or do not have obstruction of the main bile duct. IgA and serum albumin can stick to the intestinal mucosa, and other factors such as the flow rate of the perfusion, as well as transintestinal fluid movements, could influence the recovery of these polypeptides in the perfusate. In fact, neither the doubling of the perfusion rate nor the stimulation of water absorption by glucose had a significant effect on serum albumin and IgA outputs. We have also shown by these experiments that serum albumin and IgA secretion rates (in the absence of antigenic stimulation) were steady over a seven-hour perfusion period.
Assuming that the mean length of the whole small intestine intubated by the four lumen tube with an occlusive balloon is 160 cm (unpublished data) and that the secretion rate of serum albumin remains constant from the pylorus to the ileocaecal junction, the mean small intestinal clearance of serum albumin in the 10 healthy subjects we have studied would be 25 ml/day. This figure is of the same order of magnitude as that found for gastric serum albumin clearance determined by direct recovery of gastric juice.45 The sum of these two figures is nearly double the total tract clearance of serum albumin determined by Waldman's method3, which is thus probably an underestimate. Apart from its physiological interest, measurement of serum albumin losses in various parts of the intestine would allow us to determine the precise site of plasma protein losses localised in a segment of the digestive tract; this would permit a surgical resection if the normal medical treatment failed.
Radial immunodiffusion with a human serum standard is not an accurate method for a precise evaluation of IgA concentrations in intestinal juice.
Indeed, it underestimates the 1lS SA-IgA, by at least a factor of two.11 Thus, the values of IgA secretion rates reported here were purely conventional and were used only to compare in the same subjects IgA outputs under various experimental conditions. Provided an accurate measurement of S-IgA is available, the method of segmental perfusion under an occluding balloon would allow the determination of the intraintestinal output of S-IgA in the normal subject, which is at present unknown, as well as in pathological conditions (such as coaeliac disease, Crohn's disease, primary immunodeficiency syndromes, cirrhosis of the liver) where abnormal S-IgA secretion could be of pathogenic interest. 
